Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
Holding NPCE?
Track your performance easily
NPCE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.45 - $18.15
Previous CloseN/A
Volume21.31K
Average Volume (3M)81.71K
Market Cap
$355.49M
Enterprise Value$221.90M
Total Cash (Recent Filing)$5.09M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Mar 05, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding29,848,100
10 Day Avg. Volume104,578
30 Day Avg. Volume81,711
Standard Deviation0.43
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.68
Price to Cash Flow (P/CF)-49.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.62
Enterprise Value/Revenue2.90
Enterprise Value/Gross Profit4.61
Enterprise Value/Ebitda-10.31
Forecast
1Y Price Target
$14.60Price Target Upside22.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
NeuroPace News
PremiumCompany Announcements
NeuroPace to Present at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
NeuroPace Strengthens Board and Reports Strong 2024 Results
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NPCE FAQ
What was NeuroPace’s price range in the past 12 months?
NeuroPace lowest stock price was $5.45 and its highest was $18.15 in the past 12 months.
What is NeuroPace’s market cap?
NeuroPace’s market cap is $355.49M.
When is NeuroPace’s upcoming earnings report date?
NeuroPace’s upcoming earnings report date is Mar 05, 2025 which is in 46 days.
How were NeuroPace’s earnings last quarter?
NeuroPace released its earnings results on Nov 12, 2024. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.269 by $0.079.
Is NeuroPace overvalued?
According to Wall Street analysts NeuroPace’s price is currently Undervalued.
Does NeuroPace pay dividends?
NeuroPace does not currently pay dividends.
What is NeuroPace’s EPS estimate?
NeuroPace’s EPS estimate is -0.24.
How many shares outstanding does NeuroPace have?
NeuroPace has 29,848,100 shares outstanding.
What happened to NeuroPace’s price movement after its last earnings report?
NeuroPace reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.269. Following the earnings report the stock price went up 28.151%.
Which hedge fund is a major shareholder of NeuroPace?
Currently, no hedge funds are holding shares in NPCE
---
NeuroPace Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.60 (22.59% Upside)
$14.60 (22.59% Upside)
Blogger Sentiment
Bullish
NPCE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 3.5%
Last 30 Days ▲ 3.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.58%
12-Months-Change
Fundamentals
Return on Equity
-214.55%
Trailing 12-Months
Asset Growth
-3.02%
Trailing 12-Months
Company Description
NeuroPace
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
---
NPCE Company Deck
---
NPCE Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong revenue growth, strategic leadership hires, and successful programs like Project CARE contributing to growth. Although there are some challenges such as slightly decreased gross margins and increased operating expenses, the company demonstrated financial discipline and improved its cash position.Read More>---
NPCE Stock 12 Month Forecast
Average Price Target
$14.60
▲(22.59% Upside)
Technical Analysis
Best Analysts Covering NPCE
1 Year
1 Year Success Rate
15/18 ratings generated profit
1 Year Average Return
+64.72%
reiterated a buy rating 9 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +64.72% per trade.
---